GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Beneish M-Score

PuriBlood Medical Co (ROCO:6847) Beneish M-Score : -0.68 (As of Apr. 09, 2025)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.68 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for PuriBlood Medical Co's Beneish M-Score or its related term are showing as below:

ROCO:6847' s Beneish M-Score Range Over the Past 10 Years
Min: -0.78   Med: -0.15   Max: 7.12
Current: -0.68

During the past 6 years, the highest Beneish M-Score of PuriBlood Medical Co was 7.12. The lowest was -0.78. And the median was -0.15.


PuriBlood Medical Co Beneish M-Score Historical Data

The historical data trend for PuriBlood Medical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Beneish M-Score Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - 7.12 0.38 -0.78 -0.68

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -0.78 - -0.68 -

Competitive Comparison of PuriBlood Medical Co's Beneish M-Score

For the Diagnostics & Research subindustry, PuriBlood Medical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's Beneish M-Score falls into.


;
;

PuriBlood Medical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PuriBlood Medical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5+0.528 * 8.197+0.404 * 1.0297+0.892 * 0.9114+0.115 * 0.9841
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1722+4.679 * -0.294676-0.327 * 1.1811
=-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was NT$8.5 Mil.
Revenue was NT$125.3 Mil.
Gross Profit was NT$6.5 Mil.
Total Current Assets was NT$154.7 Mil.
Total Assets was NT$265.5 Mil.
Property, Plant and Equipment(Net PPE) was NT$54.9 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$8.1 Mil.
Selling, General, & Admin. Expense(SGA) was NT$31.0 Mil.
Total Current Liabilities was NT$39.9 Mil.
Long-Term Debt & Capital Lease Obligation was NT$43.7 Mil.
Net Income was NT$-51.6 Mil.
Gross Profit was NT$0.0 Mil.
Cash Flow from Operations was NT$26.6 Mil.
Total Receivables was NT$18.6 Mil.
Revenue was NT$137.4 Mil.
Gross Profit was NT$58.7 Mil.
Total Current Assets was NT$201.3 Mil.
Total Assets was NT$320.5 Mil.
Property, Plant and Equipment(Net PPE) was NT$53.6 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$7.8 Mil.
Selling, General, & Admin. Expense(SGA) was NT$29.0 Mil.
Total Current Liabilities was NT$34.7 Mil.
Long-Term Debt & Capital Lease Obligation was NT$50.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(8.46 / 125.268) / (18.564 / 137.442)
=0.067535 / 0.135068
=0.5

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(58.665 / 137.442) / (6.523 / 125.268)
=0.426835 / 0.052072
=8.197

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (154.655 + 54.876) / 265.512) / (1 - (201.26 + 53.617) / 320.5)
=0.210842 / 0.204752
=1.0297

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=125.268 / 137.442
=0.9114

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.765 / (7.765 + 53.617)) / (8.095 / (8.095 + 54.876))
=0.126503 / 0.128551
=0.9841

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(30.973 / 125.268) / (28.991 / 137.442)
=0.247254 / 0.210933
=1.1722

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((43.701 + 39.893) / 265.512) / ((50.771 + 34.663) / 320.5)
=0.314841 / 0.266565
=1.1811

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-51.595 - 0 - 26.645) / 265.512
=-0.294676

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PuriBlood Medical Co has a M-score of -0.68 signals that the company is likely to be a manipulator.


PuriBlood Medical Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines